scholarly journals Concomitant chronic spontaneous urticaria treatment might hinder the diagnosis of occupational latex-induced anaphylaxis: A case report

2020 ◽  
Vol 12 (3) ◽  
pp. 174-177
Author(s):  
Laura Michelina Losappio ◽  
Corrado Mirone ◽  
Jan Walter Schroeder ◽  
Joseph Scibilia ◽  
Luca Balossi ◽  
...  

Chronic spontaneous urticaria (CSU) is a benign skin disorder usually responsive to treatment; however, at times it can be difficult to control and become very debilitating. We discuss the case of a woman with CSU that was unresponsive to H1-antihistamines who was treated with omalizumab and became pregnant during omalizumab treatment. We also considered the follow-up of the mother and newborn for 4 years after delivery. Our case report confirms that omalizumab is a safe and effective therapeutic option, after careful evaluations in terms of cost-effectiveness, in pregnant and lactating women with severe chronic urticaria. Assessment throughout follow-up confirmed a regular progression of pregnancy parameters and no adverse reaction was documented in the child from birth to 4 years of age.


2019 ◽  
Vol 7 (18) ◽  
pp. 3118-3120
Author(s):  
Petar Vojvodic ◽  
Tatjana Vlaskovic-Jovicevic ◽  
Jovana Vojvodic ◽  
Aleksandra Vojvodic ◽  
Goran Sijan ◽  
...  

As indicated by the latest scientific evidence, the lines between different fields of medicine gradually blur and overlap more and more. Psychiatry and dermatology have seen this trend in the last decade as an ever-increasing number of studies suggest the strong connection of many dermatological syndromes and diseases with psychiatric conditions and vice versa. It seems that the relationship is more intertwined than previously believed and the effects of different multidisciplinary approaches to diagnostic and treatment are being considered. The aim of this case report is to highlight the effect of psychotherapy on chronic spontaneous urticaria which is tightly related to the maladaptive stress response.


2021 ◽  
Vol 12 ◽  
Author(s):  
Shuang-Lu Liao ◽  
Miao Yu ◽  
Zuo-Tao Zhao ◽  
Marcus Maurer

Most chronic spontaneous urticaria (CSU) patients are female, and pregnancy can aggravate the disease activity of patients, but little is known about the efficacy and safety of omalizumab in pregnant CSU patients. We report two pregnant CSU patients treated with omalizumab and review the published information on omalizumab treatment during 11 pregnancies. The outcomes reported on patients with known pregnancies showed they had normal pregnancies and healthy babies as well as complete control of their CSU. The two new cases we reported support the view that omalizumab could be an effective and safe treatment option for pregnant and breastfeeding CSU patients. Further high-quality studies need to be carried out in order to obtain more information on the long-term efficacy and safety of the use of omalizumab during pregnancy in patients with chronic urticaria, including CSU.


2022 ◽  
Vol 13 ◽  
pp. 215265672110684
Author(s):  
Stephanie G Brooks ◽  
Anna M De Jong ◽  
Mina Abbaslou ◽  
Gordon Sussman

New adverse reactions to the COVID-19 vaccines are being identified as vaccination rates increase worldwide. Recently, there have been two reports of Moderna (mRNA-1273) vaccine induced relapse of chronic spontaneous urticaria (CSU) that was previously well controlled. Herein, we report a case of AstraZeneca/Oxford (ChAdOx1) vaccine triggered CSU in a patient with no history of CSU with achieved remission.


2021 ◽  
Vol 17 (4) ◽  
pp. 85-89
Author(s):  
Inna A. Larkova ◽  
Vera A. Revyakina

The diagnostics and treatment of chronic urticaria is still a pressing problem for specialists of different profiles. Despite the fact that the first line drugs for urticaria treatment are non-sedating H1- antihistamines, there are a number of patients who do not respond to these medications even in their increased doses. This article presents clinical cases of anti-IgE-therapy efficacy in children suffering from urticaria and angioedema. CONCLUSION: The clinical cases demonstrate current possibilities of successful and safe anti-IgE-therapy of various clinical manifestations of chronic spontaneous urticaria and angioedema in children.


2020 ◽  
Vol 33 (02) ◽  
pp. 116-119
Author(s):  
Abhijit Dutta ◽  
Ranita Nath ◽  
Shubhamoy Ghosh

AbstractUrticaria or nettle rash is an inflammatory clinical condition principally due to hypersensitive reaction manifest as wheals and/or angioedema at various locations of the body. Chronic spontaneous urticaria constitutes a small percentage among the class of urticaria in which recurrence persists for more than 6 months without any identifiable cause. However, mostly, it is idiopathic, and very rarely it represents some serious internal disease. Clinical history and some special biochemical markers help in making the diagnosis.A patient suffering from chronic spontaneous urticaria of 2-year duration, which showed a poor response to conventional treatment, has been presented here. After a thorough clinical evaluation, Hepar sulphuris 6c, and in successive visits, Hepar sulphuris 30c were prescribed when needed. The response and severity of the case were evaluated by using patient-reported Visual Analogue Scale and Chronic Urticaria Quality of Life Scale at the baseline and subsequent visits. The case responded very well with no further recurrence in successive 6 months after the completion of the treatment.This case report demonstrates improvement of symptoms as well as the reduction in the recurrence of such chronic and complicated cases of urticaria with homoeopathic treatment.


Sign in / Sign up

Export Citation Format

Share Document